Some superscripts and subscripts in Tables 3 and 4 were typeset incorrectly. The correct tables are reproduced here.
Summary of analysis models for the pharmacokinetic parameters of flecainide
Number
Model equation
760.9 11.5 vs 4 P<0.005 OFV, the objective function value (−2 log likelihood); ΔOFV, difference in OFV; Ka=0.6 (fixed); WT is body weight (kg), AGE≥70 is one for 70 years or over and 0 for otherwise, SEX is 1 for females and 0 for males, Scr is serum creatinine concentration (mg/dL), EM, IM and PM number of EM, IM and PM (poor metabolizer) alleles, respectively. *The ΔOFV greater than 3.84 (df=1) or 7.81 (df=3) was accepted as statistically significant (P<0.05). Table 4 Final population pharmacokinetic parameter estimates for flecainide WT Body weight (kg); AGE≥ 70 is 1 for 70 years or over and 0 for otherwise; SEX is 1 for females and 0 for males; Scr serum creatinine concentration (mg/dl), EM, IM and PM number of EM, IM and PM alleles, respectively. V/F Distribution volume, CL/F oral clearance
Parameter
Estimates CV% 
